Completed PHASE4 INTERVENTIONAL 1-arm NCT02067117

Demonstrate the Lot-to-lot Consistency of 3 Consecutive Batches and to Evaluate the Efficacy and Safety of GC FLU®Pre-filled Syringe Injection and 'GC FLU®Injection' Administration.

Sponsor: Green Cross Corporation

Interventions GC FLU® Injection, GC FLU® Pre-filled Syringe Injection

Updated 6 times since 2017 Last updated: Feb 18, 2014 Started: Oct 31, 2010 Primary completion: Nov 30, 2010 Completion: Nov 30, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Prevention of Influenza and is currently completed. Green Cross Corporation leads this study, which shows 6 recorded versions since 2010 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jul 2022 — Jul 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2022 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Oct 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Green Cross Corporation

Data source: GC Biopharma Corp

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.